|
Retraction
for
Brinkmeier et al.,
© 2006 American Academy of Neurology Partial Retraction Partial Retraction of Correspondence about "The pentapeptide QYNAD does not block voltage-gated sodium channels"Ulm and Greifswald, Germany
We learned from one of the authors of the above Correspondence, Reinhardt Rüdel, PhD, and the President of the University of Ulm, Professor Dr. K.J. Ebeling, that co-author Peter Aulkemeyer, PhD, committed scientific fraud. The following sentence from the Correspondence was based upon his fraudulent experimentation and is hereby retracted: "We have now installed the more sensitive ion trap technique for mass detection and quantification and find QYNAD and pyQYNAD in CSF samples of all assessed MS and of GBS patients, but not of controls."
published as Correspondence in Neurology 2003;60:1871–1872
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||